Samsung SDS announced that it received the International Air Transport Association (IATA) Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification.
Samsung SDS announced its preliminary earnings for 2023, which showed revenue of KRW 13.2768 trillion and operating profit of KRW 808.2 billion.
Samsung SDS analyzed cybersecurity issues that occurred throughout the world in the previous year, and selected five major cybersecurity threats to be aware of in 2024.
